CamPARI Clinic, Addenbrooke's Hospital & University of Cambridge, Cambridge, UK; Department of Diagnostic and Interventional Radiology, University Hospital Cologne, Cologne, DE, Germany.
CamPARI Clinic, Addenbrooke's Hospital & University of Cambridge, Cambridge, UK; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
Eur J Radiol. 2017 Oct;95:307-313. doi: 10.1016/j.ejrad.2017.08.017. Epub 2017 Aug 24.
To evaluate sub-differentiation of PI-RADS-3 prostate lesions using pre-defined T2- and diffusion-weighted (DWI) MRI criteria, to aid the biopsy decision process.
143 patients with PIRADS-3 index lesions on MRI underwent targeted transperineal-MR/US fusion biopsy. Radiologists with 2 and 7-years experience performed blinded retrospective second-reads using set criteria and assigned biopsy recommendations. Inter-reader agreement, Gleason score (GS), positive (PPV) predictive values (±95% confidence intervals) were calculated and compared by Fisher's exact test with Bonferroni-Hom correction.
43% (61/143) patients had GS 6-10 and 21% (30/143) GS≥3+4 cancer. For peripheral zone lesions, significant differences in any cancer detection were found for shape (0.26±0.13 geographical vs. 0.69±0.23 rounded; p=0.0055) and ADC (mild 0.21±0.12 vs marked 0.81±0.19; p=0.0001). For transition zone, significantly increased cancer detection was shown for location (anterior 0.63±0.15 vs. mid/posterior 0.31±0.14; p=0.0048), border (pseudo-capsule 0.32±0.14 vs. ill-defined 0.61±0.15; p=0.0092), and ADC (mild 0.35±0.12 vs marked restriction 0.68±0.17; p=0.0057). Biopsy recommendations had 62% inter-reader agreement (89/143). Experienced reader PPVs were significantly higher for any cancer with "biopsy-recommended" 0.61±0.11 vs. "no biopsy" 0.21±0.10 (p=0.0001), and for GS 7-10 cancers: 0.32±0.10 vs. 0.08±0.07, respectively (p=0.0003).
Identification of certain objective imaging criteria as well as a subjective biopsy recommendation from an experienced radiologist can help to increase the predictive value of equivocal prostate lesions and inform the decision making process of whether or not to biopsy.
使用预定义的 T2 和扩散加权(DWI)MRI 标准评估 PI-RADS-3 前列腺病变的亚分级,以辅助活检决策过程。
143 例 MRI 上 PI-RADS-3 指数病变的患者接受了经会阴-MR/US 融合靶向活检。具有 2 年和 7 年经验的放射科医生使用设定的标准进行了盲法回顾性二次阅读,并给出了活检建议。使用 Fisher 精确检验和 Bonferroni-Hom 校正比较了读者间的一致性、Gleason 评分(GS)和阳性(PPV)预测值(±95%置信区间)。
43%(61/143)的患者 GS 为 6-10,21%(30/143)的患者 GS≥3+4 癌症。对于外周带病变,形状(0.26±0.13 为不规则形 vs. 0.69±0.23 为圆形;p=0.0055)和 ADC 值(轻度 0.21±0.12 vs. 显著受限 0.81±0.19;p=0.0001)有显著差异。对于移行带,位置(前区 0.63±0.15 vs. 中区/后区 0.31±0.14;p=0.0048)、边界(假包膜 0.32±0.14 vs. 不清晰 0.61±0.15;p=0.0092)和 ADC 值(轻度 0.35±0.12 vs. 显著受限 0.68±0.17;p=0.0057)与癌症检出率显著相关。有 62%的读者间活检建议具有一致性(89/143)。经验丰富的读者对于“推荐活检”的任何癌症的 PPV 明显高于“不推荐活检”,分别为 0.61±0.11 vs. 0.21±0.10(p=0.0001),对于 GS 7-10 癌症的 PPV 也明显高于后者,分别为 0.32±0.10 vs. 0.08±0.07(p=0.0003)。
识别某些客观成像标准以及经验丰富的放射科医生的主观活检建议,可以帮助提高不确定前列腺病变的预测值,并为是否进行活检提供决策依据。